Literature DB >> 15101491

Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.

Andrew H Soll1, Ronnie Fass.   

Abstract

Although gastroesophageal reflux disease (GERD) is frequently referred to as a continuous spectrum, it is more useful to consider GERD as 2 discrete entities with several subsets that differ in pathophysiology, clinical presentation, natural history, and therapy. One entity is classic severe acid reflux with erosive esophagitis and its complications. Barrett's esophagus is an important subset of this group, with markedly increased acid exposure and an increased risk of adenocarcinoma. The second entity is nonerosive reflux disease (NERD) with minimal or no esophagitis. Patients with NERD do not develop local mucosa complications, like stricture or Barrett's esophagus, but their symptom severity can equal that of erosive esophagitis. Acid is involved in the symptoms of many but not all NERD patients. This acid dependence is evident either as an increase in esophageal acid reflux or a hypersensitivity to acid, and both generally respond well to proton pump inhibitor (PPI) therapy. NERD patients who are not acid-dependent have what is called functional heartburn; GERD-like symptoms are present, but there is no obvious involvement of refluxed acid. An important subset of GERD is refractory GERD, which consists of patients who fail aggressive PPI therapy. Parallel findings with other refractory syndromes can be anticipated; however, there are indications that psychosocial factors play a major role in refractory GERD, and these patients may benefit more from an integrated biopsychosocial approach. Diagnosis of GERD is usually made on clinical grounds, often supplemented by a therapeutic trial with antisecretory agents. Endoscopy is reserved for patients with alarm symptoms, such as dysphagia, anemia, or weight loss, or to detect Barrett's esophagus. Endoscopy is not useful to exclude the diagnosis of GERD because it will be negative in 70% of cases in primary care. Ambulatory 24-hour esophageal pH monitoring is necessary only when the diagnosis is in doubt, the patient fails medical management, or surgery is contemplated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15101491     DOI: 10.1016/s1098-3597(03)90095-0

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  5 in total

1.  Study of the pharmacokinetics and intragastric pH of rabeprazole given as successive intravenous infusion to healthy Chinese volunteers.

Authors:  Yongqing Wang; Yaozong Yuan; Ling Meng; Hongwei Fan; Jianming Xu; Hongwen Zhang; Meifeng Wang; Hongyu Yuan; Ning Ou; Haibo Zhang; Yang Chao; Ruihua Shi
Journal:  Eur J Clin Pharmacol       Date:  2010-11-26       Impact factor: 2.953

2.  The frequency of histological features mimicking reflux esophagitis: a study in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Lina Forssell; Gene B Hubbard
Journal:  In Vivo       Date:  2008 Nov-Dec       Impact factor: 2.155

3.  Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease.

Authors:  Abbas Arj; Zeinab Ghaleh Takizadeh; Hamireza Gilassi; Mohsen Razavizadeh
Journal:  Caspian J Intern Med       Date:  2022

4.  Regurgitation in healthy and non healthy infants.

Authors:  Flavia Indrio; Giuseppe Riezzo; Francesco Raimondi; Luciano Cavallo; Ruggiero Francavilla
Journal:  Ital J Pediatr       Date:  2009-12-09       Impact factor: 2.638

5.  The influence of psychological factors on the outcomes of laparoscopic Nissen fundoplication.

Authors:  Laurent Biertho; Dutta Sanjeev; Herawati Sebajang; Marty Antony; Mehran Anvari
Journal:  Ann Surg Innov Res       Date:  2007-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.